Trial · NCT04382326
Results by group638
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 638
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Redness: Any | 25.5 | 95% Confidence Interval 22.8 to 28.3 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Redness: Any | 24.6 | 95% Confidence Interval 22.0 to 27.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Redness: Mild | 21.5 | 95% Confidence Interval 18.9 to 24.1 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Redness: Mild | 22.3 | 95% Confidence Interval 19.7 to 25.0 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Redness: Moderate | 4.0 | 95% Confidence Interval 2.9 to 5.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Redness: Moderate | 2.4 | 95% Confidence Interval 1.5 to 3.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Redness: Severe | 0 | 95% Confidence Interval 0.0 to 0.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Redness: Severe | 0 | 95% Confidence Interval 0.0 to 0.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Swelling: Any | 16.4 | 95% Confidence Interval 14.2 to 18.9 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Swelling: Any | 18.8 | 95% Confidence Interval 16.4 to 21.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Swelling: Mild | 11.5 | 95% Confidence Interval 9.6 to 13.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Swelling: Mild | 14.7 | 95% Confidence Interval 12.5 to 17.1 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Swelling: Moderate | 4.8 | 95% Confidence Interval 3.6 to 6.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Swelling: Moderate | 4.1 | 95% Confidence Interval 2.9 to 5.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Swelling: Severe | 0.1 | 95% Confidence Interval 0.0 to 0.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Swelling: Severe | 0 | 95% Confidence Interval 0.0 to 0.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Pain at the injection site: Any | 49.1 | 95% Confidence Interval 46.0 to 52.3 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Pain at the injection site: Any | 45.3 | 95% Confidence Interval 42.1 to 48.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 20vPnC | Pain at the injection site: Mild | 30.6 | 95% Confidence Interval 27.8 to 33.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 7 Days After Dose 1 | 13vPnC | Pain at the injection site: Mild | 30.4 | 95% Confidence Interval 27.5 to 33.4 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04382326/results